Cargando…

Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells

Prostate cancer (PCa) is the second most common malignancy and is the fifth leading cause of cancer mortality among men globally. Docetaxel‐based therapy remains the first‐line treatment for metastatic castration‐resistant prostate cancer. However, dose‐limiting toxicity including neutropenia, myelo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nalairndran, Geetha, Chung, Ivy, Abdul Razack, Azad Hassan, Chung, Felicia Fei‐Lei, Hii, Ling‐Wei, Lim, Wei‐Meng, Looi, Chin King, Mai, Chun‐Wai, Leong, Chee‐Onn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419172/ https://www.ncbi.nlm.nih.gov/pubmed/34322995 http://dx.doi.org/10.1111/jcmm.16684

Ejemplares similares

Phosphoinositide‐dependent Kinase‐1 (PDPK1) regulates serum/glucocorticoid‐regulated Kinase 3 (SGK3) for prostate cancer cell survival
por: Nalairndran, Geetha, et al.
Publicado: (2020)

Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
por: Looi, Chin King, et al.
Publicado: (2021)

The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?
por: Looi, Chin-King, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic Cancer
por: Looi, Chin-King, et al.
Publicado: (2022)

Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells
por: Hii, Ling-Wei, et al.
Publicado: (2021)

Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
por: Looi, Chin-King, et al.
Publicado: (2019)

The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma
por: Hii, Ling-Wei, et al.
Publicado: (2019)

Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma
por: Pua, Lesley Jia Wei, et al.
Publicado: (2022)

Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases
por: Sim, Wynne, et al.
Publicado: (2022)

Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion
por: Gan, Li-Lian, et al.
Publicado: (2020)

Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1
por: Hii, Ling-Wei, et al.
Publicado: (2020)

Impact of Microplastics and Nanoplastics on Human Health
por: Yee, Maxine Swee-Li, et al.
Publicado: (2021)

Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway
por: Soo, Hsien-Chuen, et al.
Publicado: (2017)

Advances in Nanomaterials Used in Co-Delivery of siRNA and Small Molecule Drugs for Cancer Treatment
por: Chung, Shei Li, et al.
Publicado: (2021)

GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
por: Karanika, Styliani, et al.
Publicado: (2015)

Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)
por: Chung, Felicia Fei-Lei, et al.
Publicado: (2017)

Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer
por: Wen, Wei Xiong, et al.
Publicado: (2019)

Anti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine Agent
por: Batista de Carvalho, Ana L. M., et al.
Publicado: (2016)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021)

Schisandrin B synergizes docetaxel-induced restriction of growth and invasion of cervical cancer cells in vitro and in vivo
por: Yan, Chunmei, et al.
Publicado: (2020)

Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
por: Tiong, Kai Hung, et al.
Publicado: (2016)

Muslim Prayer Movements as an Alternative Therapy in the Treatment of Erectile Dysfunction: A Preliminary Study
por: Ibrahim, Fatimah, et al.
Publicado: (2013)

Itch and Janus Kinase Inhibitors
por: HAN, Yujin, et al.
Publicado: (2023)

Triclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformans
por: Movahed, Elaheh, et al.
Publicado: (2016)

Docetaxel-related interstitial pneumonitis
por: Wang, Chung-Jen, et al.
Publicado: (2015)

Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
por: Damsky, William, et al.
Publicado: (2020)

Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment
por: Liu, Shuying, et al.
Publicado: (2023)

Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment
por: Liu, Shuying, et al.
Publicado: (2023)

Additivity vs. Synergism: Investigation of the Additive Interaction of Cinnamon Bark Oil and Meropenem in Combinatory Therapy
por: Yang, Shun-Kai, et al.
Publicado: (2017)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012)

Janus Kinase Inhibitors and Cell Therapy
por: Assal, Amer, et al.
Publicado: (2021)

Biofunctional Janus particles promote phagocytosis of tumor cells by macrophages
por: Zhang, Ya-Ru, et al.
Publicado: (2020)

Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification
por: Wu, Yuan Seng, et al.
Publicado: (2016)

Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
por: Quadri, Iman, et al.
Publicado: (2023)

Janus-faced citrate in aging and metabolism
por: Lin, Wei-Sheng, et al.
Publicado: (2022)

Amphiphilic Janus Particles Confined in Symmetrical and Janus-Like Slits
por: Baran, Łukasz, et al.
Publicado: (2023)

Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020)

Drug-related problems in patients with erectile dysfunctions and multiple comorbidities
por: Huri, Hasniza Zaman, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tmva597qp5cbp3dqq0egd1i1v2